Washington D.c. Veterans Affairs Medical Center

This study looks at whether the drugs finerenone and empagliflozin, alone or together, can protect kidney cells in African American veterans with diabetic kidney disease. Researchers will measure markers of kidney health in urine and blood. The goal is to find better ways to slow…